MarcLenerMD

PubMed

• 15 citations
  The effects of ketamine on typical and atypical depressive symptoms.
  Lawrence Park, David A. Luckenbaugh, S. J. Pennybaker, Matthew Hopkins, Ioline D. Henter, Marc S. Lener, Bashkim Kadriu, Elizabeth D. Ballard, Carlos A. Zarate> ;Acta Psychiatrica Scandinavica. 2020 Nov 1
• 21 citations
  Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder.
  Lawrence Park, Maura L. Furey, Allison C. Nugent, Cristan Farmer, Jessica Ellis, Joanna Szczepanik, Marc S. Lener, Carlos A. Zarate> ;The International Journal of Neuropsychopharmacology. 2019 Jan 1
• 41 citations
  Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder.
  Bashkim Kadriu, Philip W. Gold, David A. Luckenbaugh, Marc S. Lener, Elizabeth D. Ballard, Mark J. Niciu, Ioline D. Henter, Lawrence Park, R T De Sousa, Peixiong Yuan,...> ;Molecular Psychiatry. 2018 Jul 1
• 3 citations
  Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability.
  Bashkim Kadriu, Shiwen Yuan, Cristan Farmer, Allison C. Nugent, Marc S. Lener, Mark J. Niciu, Minkyung Park, Aaron Yazdian, Elizabeth D. Ballard, Fritz A. Henn, Ioline...> ;Journal of Clinical Psychopharmacology. 2018 Jun 1
• 1 citations
  RETRACTED: F173. Negative Trial of Scopolamine in Major Depressive Disorder Does Not Demonstrate Neurophysiological Changes Seen With the Antidepressant Response of Ke...
  Lawrence Park, Maura L. Furey, Allison C. Nugent, Cristan Farmer, Jessica M. Ellis, Joanna Szczepanik, Marc S. Lener, Carlos A. Zarate> ;Biological Psychiatry. 2018 May 1
• 48 citations
  Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales.
  Elizabeth D. Ballard, Julia S. Yarrington, Cristan Farmer, Marc S. Lener, Bashkim Kadriu, Níall Lally, Deonte Williams, Rodrigo Machado-Vieira, Mark J. Niciu, Lawrence...> ;Journal of Affective Disorders. 2018 Apr 15
• 15 citations
  The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder
  Mark J. Niciu, Nicolas D. Iadarola, Dipavo Banerjee, David A. Luckenbaugh, Minkyung Park, Marc S. Lener, Lawrence Park, Dawn F. Ionescu, Elizabeth D. Ballard, Nancy E....> ;Journal of Psychopharmacology. 2017 Oct 17
• 22 citations
  A Double-Blind, Placebo-Controlled, Pilot Study of Riluzole Monotherapy for Acute Bipolar Depression.
  Lawrence Park, Marc S. Lener, Matthew Hopkins, Nicolas Iadorola, Rodrigo Machado-Vieira, Elizabeth D. Ballard, Allison C. Nugent, Carlos A. Zarate> ;Journal of Clinical Psychopharmacology. 2017 Jun 1
• 256 citations
  Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine
  Marc S. Lener, Mark J. Niciu, Elizabeth D. Ballard, Minkyung Park, Lawrence Park, Allison C. Nugent, Carlos A. Zarate> ;Biological Psychiatry. 2017 May 15
• 81 citations
  Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression
  Marc S. Lener, Bashkim Kadriu, Carlos A. Zarate> ;Drugs. 2017 Feb 14
• 32 citations
  Cortical abnormalities and association with symptom dimensions across the depressive spectrum
  Marc S. Lener, Prantik Kundu, Edmund Wong, Kaitlin E. DeWilde, Cheuk Y. Tang, Priti Balchandani, James W. Murrough> ;Journal of Affective Disorders. 2016 Jan 15
• 205 citations
  Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.
  James W. Murrough, Laili Soleimani, Kaitlin E. DeWilde, Katherine A. Collins, Kyle A. Lapidus, Brian M. Iacoviello, Marc S. Lener, Marin Kautz, J. Kim, J. B. Stern, Re...> ;Psychological Medicine. 2015 Dec 1
• 73 citations
  In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature
  Marc S. Lener, Dan V. Iosifescu> ;Annals of the New York Academy of Sciences. 2015 May 1
• 54 citations
  White Matter Abnormalities in Schizophrenia and Schizotypal Personality Disorder
  Marc S. Lener, Edmund Wong, Cheuk Y. Tang, William Byne, Kim E. Goldstein, Nicholas J. Blair, M. Mehmet Haznedar, Antonia S. New, Eran Chemerinski, King-Wai Chu, Liza ...> ;Schizophrenia Bulletin. 2015 Jan 1
• 4 citations
  RGS4 and COMT risk variants are associated with brain structural alterations.
  Marc S. Lener, S.J. Goodnow, Joel Wood, Kodavali V. Chowdari, Matcheri S. Keshavan, Vishwajit L. Nimgaonkar, Konasale M. Prasad> ;Schizophrenia Research. 2013 Oct 1
• 49 citations
  Handedness, heritability, neurocognition and brain asymmetry in schizophrenia
  Amy Deep-Soboslay, Thomas M. Hyde, Joseph P. Callicott, Marc S. Lener, Beth A. Verchinski, Jose A. Apud, Daniel R. Weinberger, Brita Elvevåg> ;Brain. 2010 Oct 1
• 23 citations
  Frontal release signs and cognition in people with schizophrenia, their siblings and healthy controls.
  Thomas M. Hyde, Terry E. Goldberg, Michael F. Egan, Marc S. Lener, Daniel R. Weinberger> ;The British Journal of Psychiatry. 2007 Aug 1
• Join now to see all

Journal Articles

• Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression  
  Lener MS, Kadriu B, Zarate C, Drugs, 2/14/2017